Brinzolamide Suspension/ Drops
Product Images NDC 24208-464

2 FDA label images from Bausch & Lomb Incorporated · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Brinzolamide (NDC 24208-464). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bausch & Lomb Incorporated, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemstructure (Chemstructure)

Chemstructure (Chemstructure)
Chemical structure of brinzolamide, the active ingredient in BRINZOLAMIDE ophthalmic suspension/drops 10 mg/mL by Bausch & Lomb Incorporated. The structure shows the molecular arrangement of atoms and bonds characteristic of brinzolamide.*
FDA Label Image

Carton10ml (Carton10ml)

Carton10ml (Carton10ml)
Packaging label for Brinzolamide Ophthalmic Suspension USP 1%, an ophthalmic suspension/drop product by Bausch & Lomb Incorporated. The label indicates 10 mL bottle size, includes storage instructions, warnings, inactive ingredients, preservative information, and distribution details. The label features the brand and generic name, product strength, usage indication for eyes only, and barcodes.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.